Navigation Links
Steep Hill Laboratories and Halent Scientific Proudly Announce Historic Merger

Oakland, California (PRWEB) June 12, 2013

Steep Hill Laboratories, Inc. and Halent Scientific, the nation’s two leading cannabis testing and research companies, are pleased to announce they will be merging to form the leading analytical cannabinoid testing and research facility. The merger marks yet another leap forward in the nascent field of cannabis research, testing, and technological innovation, marrying Steep Hill’s innovation and technical prowess with Halent Scientific’s formidable research capabilities.

“We’ve worked hard to maintain a position of leadership for Steep Hill in the fields of cannabis testing and analytics,” said David Lampach, CEO and co-founder of Steep Hill Laboratories, Inc. “With this merger, we’ve achieved a new level of expertise and research ability that will ensure that Steep Hill-Halent will remain at the forefront of these fields and will also open up new avenues for providing clients with world class research, consulting, and testing methodology to further advance the industry.”

At a time when states like Washington, Colorado, and Massachusetts are mandating testing for their emerging cannabis markets, quality control is becoming paramount to ensuring consumer safety and establishing optimized regulatory frameworks. The newly merged Steep Hill-Halent is now an industry powerhouse in these areas.

“It is, indeed, exciting for us to now have an avenue for our research and methods to reach a much wider clientele,” said Donald Land, Ph.D., Chief Scientific Consultant and co-founder for Halent Scientific. “The combination of Steep Hill’s industry-leading volume and advanced analytics with Halent’s research and scientific acumen made this a very easy decision to combine forces to improve what were already world leading enterprises in the cannabis field.”

Since the release of Steep Hill Laboratory’s ground breaking QuantaCann, the first ever non-destructive marijuana testing device, dispensaries and cultivators have seen the valuable information that can be derived from in-house testing. Interest in this technology has continued to grow throughout North America, and internationally. First released in the California market in 2011, QuantaCanns are now found in Washington, Michigan, and Colorado. The Steep Hill-Halent team are working together toward the next generation of this technology.

Steep Hill Laboratories, Inc., founded in 2008, is an independently owned and operated medical cannabis screening facility located in Oakland, California. Steep Hill Lab’s mission is to assure the quality of medical cannabis through scientific analysis while actively legitimizing the cannabis industry by implementing independent standards for quality control. Steep Hill has worked in an official capacity with both state and local governments. We are the nation’s premier cannabis quality assurance and consulting company. For more information, visit and

Halent Scientific, Inc. was originally founded as Halent Laboratories in January, 2011 with the mission to provide quality assurance, safety screening, research, and extended content information to empower patients and their physicians. With over 4,000 samples tested for safety, terpenes, and the most comprehensive cannabinoid profile in the industry, Halent and its team of university consultants and principals leads the industry in cannabinoid research. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
4. ARUP Laboratories Announces Creation of Business Innovations Division
5. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
6. Aviir Laboratories Announce National Agreement With MultiPlan
7. Aviir Laboratories Announce National Agreement with Three Rivers Provider Network
8. Aviir Laboratories Announce National Agreement with Stratose
9. Produce Safety Researchers Awarded by ABC Research Laboratories
10. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
11. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
Post Your Comments:
(Date:11/24/2015)...  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... and chief executive officer, will present at the 27 th ... New York City . The presentation will be ... at 9:30 a.m. EST. and go ... least 15 minutes prior to the presentation to allow for ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Whitehouse Laboratories ... Laboratory. The new stand-alone facility will be strictly dedicated to basic USP 61, ... and existing clients the chance to have complete chemistry and micro testing performed by ...
(Date:11/23/2015)... with a certain type of lung nodule visible on lung ... cancer than men with similar nodules, according to a new ... the Radiological Society of North America ... Lung nodules are small masses of tissue in the lungs ... appearance on CT. Solid nodules are dense, and they obscure ...
(Date:11/23/2015)... Nov. 23, 2015 China Cord Blood Corporation ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its preliminary unaudited financial results for the second ... September 30, 2015. --> ... , Revenues for the second quarter of fiscal 2016 ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
Breaking Biology News(10 mins):